Andrew Somogyi
Overview
Explore the profile of Andrew Somogyi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Altree T, Pinczel A, Toson B, Loffler K, Hudson A, Zeng J, et al.
Chest
. 2024 Dec;
PMID: 39675518
Background: Low-dose morphine may be prescribed to reduce chronic breathlessness in COPD. Subjective findings suggest morphine may influence breathlessness through sleep-related mechanisms. However, concerns exist regarding opioid safety in COPD....
2.
Cognitive outcomes from the randomised, active-controlled Ketamine for Adult Depression Study (KADS)
Martin D, Harvey A, Baune B, Berk M, Carter G, Dong V, et al.
J Affect Disord
. 2024 Feb;
352:163-170.
PMID: 38378088
Background: Due to its rapid antidepressant effect, ketamine has recently been clinically translated for people with treatment-resistant depression. However, its cognitive profile remains unclear, particularly with repeated and higher doses....
3.
Ferro A, Loke Y, Lewis L, Somogyi A, Cohen A, Ritter J
Br J Clin Pharmacol
. 2014 Jan;
77(2):228-32.
PMID: 24450546
No abstract available.
4.
Katalinic N, Lai R, Somogyi A, Mitchell P, Glue P, Loo C
Aust N Z J Psychiatry
. 2013 May;
47(8):710-27.
PMID: 23661785
Objective: Narrative review of the literature on the efficacy and safety of subanaesthetic doses of ketamine for the treatment of depression. Method: Medline and PubMed databases were searched up to...
5.
Lewis L, Somogyi A, Loke Y, Ferro A, Cohen A, Ritter J
Br J Clin Pharmacol
. 2012 Dec;
75(1):1-6.
PMID: 23240642
No abstract available.
6.
Loke Y, Ferro A, Lewis L, Cohen A, Somogyi A, Ritter J
Br J Clin Pharmacol
. 2010 Dec;
71(1):3-6.
PMID: 21143495
No abstract available.
7.
Glaeser H, Drescher S, van der Kuip H, Behrens C, Geick A, Burk O, et al.
Clin Pharmacol Ther
. 2002 Mar;
71(3):131-40.
PMID: 11907487
Objectives: Intestinal metabolism and transport are now recognized as protective barriers against orally ingested xenobiotics, including drugs. However, in vitro studies of the expression and function of intestinal proteins are...